FIELD: medicine, pharmacy. SUBSTANCE: medicinal form has azithromycin and an acceptable carrier releasing an active component at the definite rate. Invention proposes a method of preparing this medicinal form and a method of treatment of patients with bacterial infection that involves administration of azithromycin in the proposed medicinal form to mammal including human patient being this medicinal form exhibits controlled- -releasing drug. EFFECT: decreased adverse effects. 71 cl, 31 tbl, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| ORAL DOSAGE FORMS OF TOFACITINIB WITH CONTINUOUS RELEASE | 2014 |
|
RU2790166C2 |
| TOFACITINIB ORAL SUSTAINED RELEASE DOSAGE FORMS | 2014 |
|
RU2674345C2 |
| METHOD OF PREPARING ANALGESICS | 2007 |
|
RU2422445C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING DIACEREIN | 2009 |
|
RU2542461C2 |
| MODIFIED RELEASE PHARMACEUTICAL COMPOSITION CONTAINING FEBUXOSTAT | 2011 |
|
RU2602188C2 |
| METHOD OF TREATMENT OF PATIENTS WITH BACTERIAL INFECTION | 1995 |
|
RU2128998C1 |
| METHODS OF TREATING GASTROINTESTINAL TRACT DISORDERS INDEPENDENTLY ON FOOD CONSUMPTION | 2014 |
|
RU2563993C1 |
| DOSAGE FORMS WITH RETARDED RELEASE OF ZIPRASIDONE | 2004 |
|
RU2351316C2 |
| APPLICATION OF METHYL NALTREXONE FOR TREATING IRRITABLE COLON SYNDROME | 2004 |
|
RU2373936C2 |
| SOLID PHARMACEUTICAL PREPARATIONS CONTAINING PHYSICAL MIXTURE OF CYCLODEXTRIN SULFOALKYL ETHER AND THERAPEUTIC AGENT | 1998 |
|
RU2173172C2 |
